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IN A previous publication, one of us
(A.W.) has described the isolation of a
tumour specific transplantation antigen
(TSTA) in the form of a cell membrane
fraction as the basis of immunogenicity
(Wolf and Avis, 1970). In this commu-
nication we report the isolation of a
soluble TSTA from the ascitic fluid ofmice
bearing the immunogenic lymphoma SL2,
the tumour specific antigenic activity
being identified serologically. The pro-
cedures used for isolating the TSTA
were similar to those employed for the
isolation of normal transplantation anti-
gens by other workers (cf Sanderson and
Welsh, 1972). Antigenic activity was
assessed by the capacity of the separated
fractions to inhibit the cytotoxicity of an
antiserum directed against the TSTA of
the tumour cells.
MATERIAL AND METHODS
The tumour.-The SL2 is a spontaneous
lymphoma which arose in a male DBA/2
mouse of our own colony (Wolf, Barfoot and
Johnson, 1972). The tumour grows from
less than 10 cells and invariably kills 100%
of the inoculated animals. Some specific
antigens are likely to reside on the cell
membranes since the injection of 2 x 107
irradiated SL2 cells readily protect DBA/2
mice against a subsequent challenge by 103
live cells and 60% of animals immunized in
this way survive a live inoculum of 104 cells.
Moreover, specific antibodies are produced in
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rabbits in response to membrane fractions
ofSL2 cells.
Allogeneic immune serum.-This anti-
serum was raised by the method of Motta
(1970). C57B1 mice received twice 2 x 107
live SL2 cells which had been incubated and
were injected together with an antiserum
obtained from other C57B1 mice containing
alloantibodies directed against normal DBA/2
lymphoid cell antigens.
Monitoring and quantitation of specific
antigenic activity.-A complement dependent
cytotoxic technique based on the release of
5'Cr from labelled target cells by a specific
antiserum was used (Wigzell, 1965). In-
hibitory tests for measuring TSTA activity
were performed by preincubation of anti-
serum with a dilution series of fractions of
ascitic fluid before adding labelled cells and
preserved guinea-pig complement (Wellcome
Reagents Ltd). Complement was used un-
absorbed, giving at the final concentration of
approximately 1: 16 a background of 10%
ofthe maximal 51Cr release. Fresh weanling
rabbit serum tested as complement source
was less reliable.
EXPERIMENTS AND RESULTS
Typingoftheantiserum
The anti-SL2 serum was titrated un-
absorbed, and absorbed with normal
DBA/2 lymphoid cells (v/v for 1 h) against
3 types of labelled cells (1) SL2 cells as
the specific target, (2) normal DBA/2
lymphoid cells as carrier ofnormal DBA/2
transplantation antigens and (3) TXL9
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cells (from an x-ray induced C57B1
lymphoma) as cells genetically different
from DBA/2 derived cells. Figure 1
shows that after absorption the antiserum
cr: I
cr-
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FIc;. 1. Allogeneic anti-SL2 serum unabsor-
bed and absorbed with normal DBA/2
lymphoid cells titrated against 51Cr-labelled
SL2 cellsand'normal DBA/2 lymphoid cells.
The figures are means ofduplicates. C 0
unabsorbed anti-serum against SL2 cells,
A-- - Aabsorbed anti-serum against SL2
cells, 0- 0 unabsorbed anti-serum against
normal DBA/2 cells,y V- absorbed anti-
serum against normal DBA/2 cells. 100%
= total releasable label by freezing and
thawing (approximately 8 x 103 ct/min for
SL2 cells and 5 x 103 ct/min for normal
DBA/2 cells). A background of 10% is
substracted.
still exhibited considerable lytic capacity
for the specific SL2 cells where the titre
against normal DBA/2 cells was almost
completely abolished, indicating the pre-
sense in the serum of an antibody popula-
tion directed against the specific SL2-
antigen. No lysis at all was observed of
TXL9 cells. The absorbed antiserum was
therefore considered to be a specific agent
suitable for the detection of the TSTA of
the SL2 lymphoma.
Isolation ofTSTA
Figure 2 illustrates the purification
procedures adopted to isolate the specific
SL2-antigen. Inhibitory tests for monit-
oring TSTA activity were performed with
all preparations, details of control tests
being given under "Quantitation of
TSTA". Ascitic fluid harvested from
12-15 tumour bearing animals was centri-
fuged at 100,000 g for 2 h and at 250,000 g
for 1 h to remove all particulate material.
Of the three ammonium sulphate precipi-
tates, only the 40-60% fraction contained
considerable specific inhibitory activity.
After dialysis and concentration this
fraction was applied to a Biogel A 0 5 m
column (32 x 500 mm). The most active
fractions (2 and 3) were pooled and re-
chromatographed on the same type of
Biogel column as before. Inhibitory frac-
tions (consisting of material between
50,000 and 100,000 mol. wt) were pooled,
dialysed against 0-005 mol Tris-phosphate
buffer pH 7-8, and applied to a DEAE-
cellulose column (250 x 22 mm). Elution
was carried out by a linear gradient from
0 005 to 0 5 mol Tris-phosphate buffer,
pH 7-8. Specific inhibitory activity was
confined to fractions eluted by 0 1-0 4 mol
buffer, the highest specific activity resid-
ing in fractions eluted between 01 and
0-2 mol buffer.
Quantitation ofTSTA
In order to quantitate the TSTA
activity, inhibitory tests were performed
with five 5-fold dilutions of all prepara-
tions. The diluted fractions were mixed
and incubated with absorbed antiserum
diluted 1: 100. After incubation for 1 h
5'Cr-labelled specific target cells and
complement were added (all components
at 30 ,al volumes) and incubation was
continued for 45 min at 37°C. With 2 ml
of Medium 199 pipetted into each tube,
the cells were spun down and aliquots of
supernatant were removed for counting
the amount of the released 51Cr.
Two types of tests were performed to
discriminate between inhibitory effects
by TSTA on the one hand and by anti-A. WOLF AND K. A. STEELE
Ascitic fluid
100,000 x g 2 h
250,000 x g 1 h
Ammonium | sulphate
40-60%
Bio | gel I
2
2 x 105-7 x 104
mol. wt
3
7 x 104-3 x 104
mol. wt
Bio gel II
2
105-7 x 104 7 x 104-5 X 104
DEAE cellulose
2
0-1-0-2
(b.m.)
3
0-2-0-3
(b.m.)
4
0*3-0*4
(b.m.)
l
4
3 x 104-1X5 x 104
mol. wt
l
4
5 X 104
5
0*4-05
(b.m.)
FIG. 2.-Isolation of specific inhibitory TSTA activity from the ascitic fluid of DBA/2 mice bearing
the SL2 lymphoma. b.m.= buffer molarity.
complementary activity or normal trans-
plantation antigens on the other. Com-
plement inhibiting activity was examined
by removing the mixture of ascitic fluid
fraction and antiserum from the incubated
test samples after sedimenting the anti-
body coated cells, before the addition of
complement, thus avoiding contact bet-
ween the latter and the fractions. Ifsuch
experiments showed a higher degree of
cytotoxicity than thQose where the same
fraction remained in the test tube for the
final cytotoxic reaction with complement,
this was taken as evidence that the frac-
tion interfered with the complement
action. (Cytotoxicity was of the same
magnitude when control anti-serum was
removed after 10 min incubation with
cells as when the antiserum remained in
the test tube.) Almost all fractions con-
taining material of molecular weight of
more than 200,000 exhibited effects on
complement and were subsequently ex-
cluded from further purification.
Tests for inhibition by normal trans-
plantation antigens were carried out using
unabsorbed antiserum and normal DBA/2
lymphoid cells. Such experiments did
exhibit much less inhibition than those
performed with absorbed antiserum and
SL2 cells and also showed a different
distribution ofthe inhibitory activity over
the examined fractions, indicating that
inhibition in the TSTA system was indeed
specific.
For calculating the relative specific
activity of the various fractions, 50%
inhibition of the cytotoxic capacity of the
control anti-serum was used as anendpoint
and the protein contents (Lowry et al.,
1951) per ml of the preparation at this
point were compared.
The purification efficiency defined in
this way is demonstrated in the Table,
which gives details of one of our best
preparations. Although there was a loss
in total activity by the purification pro-
cedure, there was a gain in specific activity
0-40% 60-80%
1
> 2 x 105
mol. wt
1
2 x 105-105
0 005-0 1
(b.m.)
c::l
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TABLE. Relative TSTA Activity at Different Stages of Purification of Ascitic Fluid of
Mice Bearing the SL2 Lymphoma (Starting Material was the Ascitic Fluid from
12 Mice andfrom Approximately 1010 Cells)
Total proteini
Sepaiatioin pioceduie (mg) Relative activity(4)
Crude ascitic fluid 500 ND(1)
Ammonium sulphate 40-60% 350 50
13iogel I Fractions 2 and 3 70 20
Biogel IL Fractions 2 and 3 13-5 4
DEAE-cellulose
Fraction 1 (0 005-0 1)(3) 0-1 NI(2)
Fraction 2 (0 1-0 2)(3) 0 2 0 2
Fraction 3 (0 2-0 3)(3) 1*5 10 *
Fraction 4 (0 3-0 4)(3) 3 0 4 -0
Fraction 5 (0 4-0 5)(3) 1*0 NI(2)
(1) Not (lonie. (see Text).
(2) No inihibition.
(3) Molarity of eluting buffer.
(4) The amount in jig protein which reduced by 50% the cytotoxicity of 1 rnl aniti-serum dilutedt 1: 100.
of 1: 250 between the ammonium sul-
phate precipitate and the DEAE fraction
2. There was also specific activity in
DEAE fraction 3. The crude ascitic
fluid was highly anti-complementary and
its TSTA activity could not be measured
as a distinct activity. No attempts were
made to absorb the anti-complementary
activity from the crude starting material.
]DISCUSSION
From the results it may be concluded
that a soluble TSTA-type activity is
present in and can be isolated from the
ascitic fluid of DBA/2 mice bearing the
SL2 lymphoma.
The specific antigenicity of crude
ascitic fluid could not be measured as a
distinct activity because of its high
content of anti-complementary material,
but TSTA was already detectable in the
40-60% ammonium sulphate precipitate.
Purification by Biogel and DEAE-cellu-
lose led to a 250-fold concentration of the
specific activity. When this fraction was
iodinated and subjected to electrophoresis
on polyacrylamide, it appeared as a single
although widely distributed component
in the,8region.
The fractionation shown was one of
two procedures resulting in preparations
of similarly good specific activity. From
eight other batches ofascitic fluid prepara-
tions were obtained which contained a
range of 15-50 times increased specific
activity, the differences due possibly to a
varying percentage of nonspecific protein
in the starting material. Attempts to
remove the nonspecific moiety from prep-
arations by absorption on a cross-linked
rabbit anti-mouse serum usually resulted
in the doubling ofthe specific activity but
there probably still remained a large
amount of contaminating, perhaps non-
antigenic or weakly antigenic, material in
the fractions. More experiments to study
this partly purified TSTA fraction, al-
though difficult by the tendency of the
material to aggregate, are in progress.
The authors wish to thank Professor
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